FDA plan would revise rules on device trials outside U.S.

02/27/2013 | GenomeWeb Daily News (free registration)

The FDA has proposed changes to its requirements for medical device clinical trials conducted outside the U.S., including mandating that manufacturers provide documentation on human subjects' informed consent as well as on trial evaluation and approval by an independent ethics panel. The proposal is up for comment through May 28.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT